|1.||Quinzii, Catarina M: 2 articles (05/2015 - 05/2009)|
|2.||Du, Xiao-Jun: 1 article (10/2015)|
|3.||Ritchie, Rebecca H: 1 article (10/2015)|
|4.||Kiriazis, Helen: 1 article (10/2015)|
|5.||McMullen, Julie R: 1 article (10/2015)|
|6.||De Blasio, Miles J: 1 article (10/2015)|
|7.||Ayer, Anita: 1 article (10/2015)|
|8.||Stocker, Roland: 1 article (10/2015)|
|9.||Cemerlang, Nelly: 1 article (10/2015)|
|10.||Qin, Chengxue: 1 article (10/2015)|
12/01/2014 - "The proteomic study indicates that the protein expression of thioredoxin domain-containing protein 12, peroxiredoxin-1, thiosulphate sulphurtransferase, calcium-binding protein 1, Annexin A2 and heat shock cognate 71 kDa protein are higher in livers from EVOO-fed rats with the CCl4 treatment compared with those from rats fed with corn oil, whereas the expression of COQ9, cAMP-dependent protein kinase type I-alpha regulatory subunit, phenylalanine hydroxylase and glycerate kinase are lower. "
01/01/1999 - "In a surgical model of liver ischemia lipid peroxidation occurs, as shown by increase of lipid peroxidation end products, endogenous CoQ9 is oxidized and mitochondrial respiration is lowered; however, pre-treatment of the rats by i.p. "
01/01/1995 - "The young rat hearts showed a 30% reduction in the mitochondrial levels of CoQ9 after ischemia and reperfusion with respect to the preischemic values (P < 0.05 and P < 0.01, respectively). "
10/01/1992 - "[Coenzyme Q9 biosynthesis in the aging myocardium after ischemia and reperfusion]."
06/01/1991 - "[Cardioprotective effect of combined use of coenzyme Q9 and cyclohexyladenosine in ischemia, reperfusion and acute myocardial infarction]."
09/01/1989 - "At 30 minutes after ischemia, alpha-tocopherol decreased to 79% of baseline, reduced ubiquinone-9 to 73%, ubiquinone-10 to 66%, and reduced ascorbate to 76%. "
06/01/1991 - "Both the coenzyme Q9 and CHA significantly reduced the incidence and duration of coronary occlusion and reperfusion arrhythmias, prevented cardiac contractile depression (heart rate.developed pressure) and increased ventricular fibrillation threshold). "
08/01/2013 - "Therefore, hearts were isolated and subjected either to 30 min coronary occlusion followed by 120 min reperfusion to measure infarct size or to 10 min aerobic perfusion to measure cardiac mevalonate pathway end-products (protein prenylation, cholesterol, coenzyme Q9, coenzyme Q10, dolichol), and 3-nitrotyrosine (oxidative/nitrosative stress marker), respectively. "
|5.||Mitochondrial Diseases (Mitochondrial Disease)
01/01/2011 - "Altered redox status of coenzyme Q9 reflects mitochondrial electron transport chain deficiencies in Caenorhabditis elegans."
05/01/2009 - "A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease."
|1.||coenzyme Q10 (CoQ10)
|2.||NADPH Oxidase (NAD(P)H oxidase)
|3.||Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
|4.||Annexin A2 (Annexin II)
|6.||Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)
|7.||Corn Oil (Oil, Corn)
|9.||Carrier Proteins (Binding Protein)